Institute of Biomedical Research Corporation New (PK)
-0.0003 (-2.44%)
Volume 657,015
Bid Price 0.0101
Ask Price 0.0127
News -
Day High 0.01325


52 Week Range


Day Low 0.0108
Company Name Stock Ticker Symbol Market Type
Institute of Biomedical Research Corporation New (PK) MRES OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0003 -2.44% 0.012 16:30:15
Open Price Low Price High Price Close Price Prev Close
0.013 0.0108 0.01325 0.012 0.0123
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
34 657,015 $ 0.011925 $ 7,835 - 0.005 - 0.0367
Last Trade Time Type Quantity Stock Price Currency
15:37:27 10,000 $ 0.012 USD


Draw Mode:

Institute of Biomedical Research Corporation New (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 12.11M 1.01B 345.00M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
6.75k $ - - - -

more financials information »

Institute of Biomedical ... (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRES Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01070.013250.01010.0114566922,1580.001312.15%
1 Month0.01610.01610.01010.0116285476,277-0.0041-25.47%
3 Months0.01590.02250.01010.0143347386,236-0.0039-24.53%
6 Months0.018750.03670.01010.0221281581,790-0.00675-36.0%
1 Year0.01220.03670.0050.0158831803,711-0.0002-1.64%
3 Years0.0005250.0450.00020.0141629988,2760.011482,185.71%
5 Years0.00070.0450.00020.013314824,7170.01131,614.29%

Institute of Biomedical ... (PK) Description

The Institute of Biomedical Research is a Nevada Corporation trading as M2Bio Science. We are a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research. M2Bios mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. As one of a handful of companies in the world, M2Bio is actively researching the magic mushroom compound psilocybin by funding research at a South African University . The exploratory research is aiming to discover novel indications for medical conditions such as depression, inflammation, and substance addiction. The company also owns and operates three consumer goods brands Medspresso, Dr. AnnaRx, and Liviana. The brands span across a wide range of premium CBD- and mushroom-infused consumer goods including bioceuticals, health and wellness, and precision foods and beverages. With operations currently based in Cape Town, South Africa the company and its brands are positioned in the high-value market segment.